D. G. Polukhin
Research Subjects
D. G. Polukhin has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Akhmetzhanova D.O.
НАО «Медицинский университет Семей
1 shared publication - Anastasia V. Batyarkina
ФГБОУ ВО «Алтайский государственный медицинский университет» Министерства здравоохранения Российской Федерации
1 shared publication - Bogdan S. Roy
Altai State Medical University, Barnaul
1 shared publication - Danil V. Osintsev
Siberian State Medical University, Tomsk
1 shared publication - Nikolay A. Dorokhov
Altai State Medical University
1 shared publication
Latest Publications
- Open Access
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 135-138
A clinical case in pediatric practice: mitochondrial DNA depletion syndrome, type 2 (myopathic form)
The paper discusses the diagnosis and treatment of mitochondrial DNA depletion syndrome (MDS), which is associated with a defect in the thymidine kinase 2 (TK2) gene. Despite the expansion of neonatal screening (up to 36 diseases, with plans to increase it to 62), the detection of MDS requires expensive whole-genome sequencing and is not yet available on a large scale. A case of a girl with TC-2-associated mitochondrial myopathy is described: the disease manifested itself at 9 months with weakness of the limbs and regression of motor skills, complicated by pneumonia, respiratory failure and cardiomyopathy. The diagnosis was confirmed genetically. The patient received therapy with deoxytimidine and deoxycytidine — the condition stabilized, new skills appeared. Long-term follow-up showed a decrease in the frequency of pneumonia, improvement of tests and a decrease in dependence on respiratory support. The importance of early genetic diagnosis and access to treatment is emphasized; research centers and telemedicine can help with this.
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 135-138
Open AccessA clinical case in pediatric practice: mitochondrial DNA depletion syndrome, type 2 (myopathic form)
The paper discusses the diagnosis and treatment of mitochondrial DNA depletion syndrome (MDS), which is associated with a defect in the thymidine kinase 2 (TK2) gene. Despite the expansion of neonatal screening (up to 36 diseases, with plans to increase it to 62), the detection of MDS requires expensive whole-genome sequencing and is not yet available on a large scale. A case of a girl with TC-2-associated mitochondrial myopathy is described: the disease manifested itself at 9 months with weakness of the limbs and regression of motor skills, complicated by pneumonia, respiratory failure and cardiomyopathy. The diagnosis was confirmed genetically. The patient received therapy with deoxytimidine and deoxycytidine — the condition stabilized, new skills appeared. Long-term follow-up showed a decrease in the frequency of pneumonia, improvement of tests and a decrease in dependence on respiratory support. The importance of early genetic diagnosis and access to treatment is emphasized; research centers and telemedicine can help with this.